Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Nov 1;160(5):1597-602.
doi: 10.1084/jem.160.5.1597.

Detection and functional studies of p60-65 (Tac antigen) on activated human B cells

Detection and functional studies of p60-65 (Tac antigen) on activated human B cells

L K Jung et al. J Exp Med. .

Abstract

A monoclonal antibody, AT-1, is shown to precipitate a p60-65 molecule identical to the Tac antigen. With AT-1, the expression of IL-2 receptors by normal activated human B cells from peripheral blood and tonsils is documented by biosynthetic and immunofluorescence studies. AT-1 precipitated a p60-65 protein from [35S]methionine-labeled activated B cells, similar to that from activated T cells. The interleukin 2 (IL-2) receptor appeared shortly after activation with anti-IgM and B cell-stimulatory factor(s). Its expression reached its peak at 60-72 h with approximately 50% of the B blasts stained by AT-1. Other modes of activation of B cells, by T cell-independent, formalin-treated staphylococci and Epstein-Barr virus, and by T cell-dependent pokeweed mitogen, also induced IL-2 receptor expression. The functional significance of this finding was investigated using recombinant IL-2 (rIL-2). While rIL-2 did not induce resting B cells to proliferate in the presence of anti-IgM, it induced activated B cells to proliferate in the absence of other factors. On the other hand, rIL-2 did not induce the differentiation of these activated B lymphocytes. These data suggest that IL-2 may play a significant role in B cell activation.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Immunol Immunopathol. 1980 Mar;15(3):301-13 - PubMed
    1. J Immunol. 1981 Apr;126(4):1393-7 - PubMed
    1. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2517-21 - PubMed
    1. J Exp Med. 1981 Jul 1;154(1):138-45 - PubMed
    1. J Immunol. 1982 Aug;129(2):469-74 - PubMed

Publication types

Substances